CCDC6-RET fusion was associated with enhanced resistance to EGFR tyrosine kinase inhibitor in EGFR-mutant NSCLC cell lines via excessive cellular proliferation43. This evidence concerns the gene EGFR and non-small cell lung carcinoma.